Watching low-risk prostate lesions with repeat MRI scans
Part of Cancer, Kidney & urinary clinical trials.
This trial uses repeated MRI scans to monitor prostate lesions that have a low chance of being aggressive cancer. It is for people who have suspicious spots but whose initial biopsies did not find high-grade cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have 1 or 2 suspicious spots (PI-RADS 3-5) on a prostate MRI.
- Your first biopsy did not find prostate cancer with a Gleason score of 2 or higher (ISUP 2-5).
- You are expected to live more than 10 years.
- You are fluent in Finnish and can cooperate with the study.
- You have no hip replacement or metal implants that would interfere with MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using advanced MRI techniques to better spot prostate cancer, aiming to reduce unnecessary biopsies. It has two parts: one calibrates MRI scanners across hospitals, the other tests the new method in patients with suspicious MRI findings.
This trial tests whether repeat MRI scans can help monitor suspicious prostate areas and avoid unnecessary biopsies. It aims to improve detection of significant prostate cancer while reducing invasive procedures.
This study explores using repeated MRI scans to catch prostate cancer early in men who have never had a biopsy. If you have a suspicious spot on an MRI, you might be able to get careful monitoring without immediate biopsy, which could help avoid unnecessary procedures.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This trial studies whether men with low-risk prostate cancer can safely avoid treatment by closely monitoring their cancer over many years. It tests a new approach to see if it is better than the current standard of care.
This trial uses special MRI scans to help track low-risk prostate cancer while you stay on active surveillance (meaning no immediate treatment). It may help your care team better understand changes in the cancer over time.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.